Epidemiological study on the malignant neoplasms of the breast in the state of Pará in the period from 2013 to 2020
DOI:
https://doi.org/10.33448/rsd-v10i7.16669Keywords:
Breast Cancer; Women's Health; Epidemiology.Abstract
Objective: To identify and characterize the diagnosed cases of breast cancer in women in the state of Pará in the period from 2013 to 2020. Method: Epidemiological, descriptive, quantitative study, using data from the Painel Oncologia Brasil, from the SUS Department of Informatics. The variables analyzed were: year of diagnosis, age group, therapeutic modality, time to start of treatment and state of diagnosis and treatment. The analysis took place using descriptive statistics in the software Bioestat 5.3. Results: 4,387 cases of breast cancer were diagnosed in the period from 2013 to 2020, with prevalence of 101.22 cases / 100 thousand women in the state. Women between 50 and 59 years of age were more affected by the disease. The treatment was carried out in the form of chemotherapy for 47% of the patients, beginning more than 60 days after diagnosis for the majority. Diagnosis and treatment were carried out in institutions in the state of residence for a significant portion of the sample. Conclusion: Breast cancer is a considerable problem in the state of Pará, affecting a significant number of women. Thus, more studies need to be carried out to identify regional aspects that influence this illness and can support strategic health measures to be taken.
References
Azevedo, D. B., Moreira, J. C., Gouveia, P. A., Tobias, G. C., & Morais Neto, O. L. (2017). Perfil das mulheres com câncer de mama. Rev enferm UFPE on line, 11(6), 2264-72.
Brasil. (2021a). Painel-Oncologia Brasil. http://tabnet.datasus.gov.br/cgi/dhdat.exe?PAINEL_ONCO/PAINEL_ONCOLOGIABR.def
Brasil. (2021b). População residente: estudo de estimativas populacionais por município, idade e sexo, 2000-2020 – Brasil. http://tabnet.datasus.gov.br/cgi/tabcgi.exe?popsvs/cnv/popbr.def
Cabral, A. L. L. V., Giatti, L., Casale, C., & Cherchiglia, M. L. (2019). Vulnerabilidade social e câncer de mama: diferenciais no intervalo entre o diagnóstico e o tratamento em mulheres de diferentes perfis sociodemográficos. Ciência & Saúde Coletiva, 24(2), 613-622.
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., Senkus, E., & ESMO Guidelines Committee.(2019). Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, 30(8), 1194–1220.
Carlos Leite, G., Ruhnke, B. F., & Valejo, F. A. M. (2021). Correlação entre tempo de diagnóstico, tratamento e sobrevida em pacientes com câncer de mama: uma revisão de literatura. Colloquium Vitae, 13(1), 12–16.
Centers for Disease Control and Prevention. (2020). What Is Breast Cancer?. https://www.cdc.gov/cancer/breast/basic_info/what-is-breast-cancer.htm
Constâncio, T. B., Gottems, L. B. D., Araújo, S. L., & Barros, A. F. (2020). Tempo entre diagnóstico e tratamento do câncer de mama no Distrito Federal e fatores associados. Comunicação em Ciências da Saúde, 31(1), 179-187.
European Patients’s Academy on Therapeutic Innovation. (2021). Epidemiologic concepts: incidence and prevalence. https://toolbox.eupati.eu/resources/epidemiologic-concepts-incidence-and-prevalence/
He, Z., Chen, Z., Tan, M., Elingarami, S., Liu, Y., Li, T., Deng, Y., He, N., Li, S., Fu, J., & Li, W. (2020). A review on methods for diagnosis of breast cancer cells and tissues. Cell proliferation, 53(7), e12822.
Instituto Nacional do Cancêr. (2021). Tipos de câncer: câncer de mama. https://www.inca.gov.br/tipos-de-cancer/cancer-de-mama
Instituto Brasileiro de Geografia e Estatística. (2017). Cidades e estados. https://cidades.ibge.gov.br/brasil/pa/panorama
Kameo, S. Y., Barbosa-Lima, R., Ramos, M. J. O., Fonseca, T. V., Vassilievitch, A. C., Costa, J. dos S., Santos, J. C. de O., Santos, D. K. da C., Amorim, B. F., Marinho, P. M. L., Sawada, N. O., & Silva, G. M. (2021). Perfil clínico-epidemiológico de mulheres em tratamento oncológico de carcinoma ductal invasivo da mama. Research, Society and Development, 10(1), e39110111836.
Kolak, A., Kamińska, M., Sygit, K., Budny, A., Surdyka, D., Kukiełka-Budny, B., & Burdan, F. (2017). Primary and secondary prevention of breast cancer. Ann Agric Environ Med., 24(4), 549-553.
Liu, F. C., Lin, H. T., Kuo, C. F., See, L. C., Chiou, M. J., & Yu, H. P. (2017). Epidemiology and survival outcome of breast cancer in a nationwide study. Oncotarget, 8(10), 16939-16950.
Magalhães, G., Brandão-Souza, C., Fustinoni, S. M., Matos, J. C., & Schirmer, J. (2017). Perfil clínico, sociodemográfico e epidemiológico da mulher com câncer de mama. Rev Fund Care Online, 9(2), 473-479.
Medeiros, G. C., Teodózio, C. G. C., Fabro, E. A. N., Aguiar, S. S., Lopes, A. H. M., Conte, B. C., Silva, E. V., Coelho, L. L. P., Muniz, N. F., Schuab, S. I. P. C., Bergmann, A., & Thuler, L. C. S. (2020). Fatores Associados ao Atraso entre o Diagnóstico e o Início do Tratamento de Câncer de Mama: um Estudo de Coorte com 204.130 Casos no Brasil. Revista Brasileira De Cancerologia, 66(3), e-09979.
National Cancer Institute. (2021). What Is Cancer?. https://www.cancer.gov/about-cancer/understanding/what-is-cancer
Saldanha, R. F., Xavier, D. R., Carnavalli, K. M., Lerner, K., & Barcellos, C. (2019). Estudo de análise de rede do fluxo de pacientes de câncer de mama no Brasil entre 2014 e 2016. Cadernos de Saúde Pública, 35(7), e00090918.
Sousa, S. M. M. T., Carvalho, M. G. F. M., Santos Júnior, L. A., & Mariano, S. B. C. (2019) . Acesso ao tratamento da mulher com câncer de mama. Saúde em Debate, 43(122), 727-741.
Souza, B. C., Figueiredo, F. W. S., Sousa, L. V. A., Maciel, E. S., & Adami, F. (2020). Disparidades regionais no fluxo de acesso às internações por câncer de mama no Brasil em 2004 e 2014. BMC Women's Health, 20(137).
Souza, N. H. A., Falcão, L. M. N., Nour, G. F. A., Brito, J. O., Castro, M. M., & Oliveira, M. S. (2017). Câncer de mama em mulheres jovens: estudo epidemiológico no nordeste brasileiro. SANARE, 16(2), 60-67.
Sun, Y. S., Zhao, Z., Yang, Z. N., Xu, F., Lu, H. J., Zhu, Z. Y., Shi, W., Jiang, J., Yao, P. P., & Zhu, H. P. (2017). Risk Factors and Preventions of Breast Cancer. International journal of biological sciences, 13(11), 1387-1397.
Tong,W. S. C., Wu, M., Cho, W. C. S., & To, K. K. W. (2018). Recent Advances in the Treatment of Breast Cancer. Frontiers in Oncology, 8(227).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Inácio Santos das Neves; Amanda Carolina Silva de Aviz; Camila de Jesus Prestes da Cruz; Edilene Gemaque Leal; Elaine Samara Pinheiro Mendes da Silva; Jamille Marcelle Ribeiro Costa; Juliane de Jesus Rodrigues Teles; Keila Ozório Fernandes Barbosa; Kodjo Vignonhouandé Jean-Fredich Odilon Nazeba ; Letícia Lôide Pereira Ribeiro; Márcia Soraya Quaresma Vera Cruz; Maria Gisele Sousa de Sousa; Thalia Otta Ferreira Milanni; Rosana de Souza Monteiro ; Wanessa Maiellen Coelho de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
